Reports for Neurosterix Pharma Sàrl
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About Neurosterix Pharma Sàrl
- Neurosterix Pharma Sàrl with its legal headquarters in Genève is active. Neurosterix Pharma Sàrl operates in the sector «Research and development».
- The management of the company Neurosterix Pharma Sàrl, entered in the trade register on the 27.03.2024, consists of 7 persons.
- The last commercial register change was made on 24.11.2025. All changes can be viewed under the section «Notifications» and saved as a PDF.
- The reported UID is the following: CHE-330.853.813.
- The address is identical with 23 other active companies. These include: Ability Neurotech SA, Aleos Bio SA, BrainQuant SA.
Management (7)
Management board
newest authorized signatories
Edward Allan Keysor,
Dr. Nicolas Simon Dommer,
Frederick Callori,
Jean-Philippe François Christian Rocher,
Mikhail Kalinichev
Commercial register information
Entry in the commercial register
27.03.2024
Legal form
Limited liability company
Legal headquarters of the company
Genève
Commercial Registry Office
GE
Commercial register number
CH-660.1.119.024-3
UID/VAT
CHE-330.853.813
Sector
Research and development
Purpose (Original language)
La recherche, le développement, la production, la fabrication et la commercialisation de produits pharmaceutiques, biologiques ou analogues. La Société peut également en Suisse et à l'étranger: créer des succursales ou des filiales, prendre des intérêts et, plus généralement, participer à toute entreprise similaire; faire, pour son propre compte ou pour le compte de tiers, toutes autres opérations financières, commerciales, mobilières ou immobilières se rapportant directement ou indirectement à son but ou jugées propres à le favoriser; et prêter de l'argent ou accorder des garanties aux associés ou à des tiers, à condition que cela serve les intérêts de la Société.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| BDO SA | Vernier | 23.12.2024 | ||
Other company names
Past and translated company names
- Neurosterix Pharma LLC
Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: Neurosterix Pharma Sàrl
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006493162, Commercial Registry Office Geneva, (660)
Neurosterix Pharma Sàrl, à Genève, CHE-330.853.813 (FOSC du 03.10.2025, p. 0/1006449648). Thoulouze ép. Ancey Nathalie Céline n'est plus directrice;
ses pouvoirs sont radiés.
Publication number: HR02-1006449648, Commercial Registry Office Geneva, (660)
Neurosterix Pharma Sàrl, à Genève, CHE-330.853.813 (FOSC du 03.06.2025, p. 0/1006347581). Signature individuelle a été conférée à Keysor Edward Allan, des USA, à Medfield, USA.
Publication number: HR02-1006347581, Commercial Registry Office Geneva, (660)
Neurosterix Pharma Sàrl, à Genève, CHE-330.853.813 (FOSC du 23.12.2024, p. 0/1006214249). Dyer Timothy n'est plus gérant;
ses pouvoirs sont radiés. Callori Frederick, des USA, à Marblehead, USA, est gérant unique avec signature individuelle. Signature individuelle a été conférée à Dommer Nicolas Simon, de Bütschwil-Ganterschwil, à Bâle
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.